Ep 44 – Latest thinking and evidence on chronic kidney disease

GPnotebook Podcast

Apr 29, 2022•22 min•Ep. 44

--:--

Listen in podcast apps:

Apple Podcasts

Spotify

Download

Listen to this episode in Metacast mobile app

Don't just listen to podcasts. Learn from them with transcripts, summaries, and chapters for every episode. Skim, search, and bookmark insights. Learn more

Episode description

In this episode, which has been recorded for Chronic Conditions Month 2022, Dr Yassir Javaid (Cardiovascular and Diabetes Lead, Northamptonshire CCG) and Dr Patrick Holmes (GP, Darlington) examine the latest developments in renal medicine, with a focus on assessing and managing chronic kidney disease (CKD). What role do sodium–glucose cotransporter 2 inhibitors have in the management of the condition, both in people with diabetes and those without diabetes?

Access episode show notes containing key references and take-home points at: https://gpnotebook.com/en-GB/podcasts/renal-medicine/ep-44-latest-thinking-and-evidence-on-chronic-kidney-disease.

Did you know? With GPnotebook Pro, you can earn CPD credits by tracking the podcast episodes you listen to. Learn more.

For the best experience, listen in Metacast app for iOS or Android